RANKL

Receptor activator of nuclear factor kappa-Β ligand (RANKL), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), TNF-related activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and osteoclast differentiation factor (ODF), is a protein that in humans is encoded by the TNFSF11 gene.

TNFSF11
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesTNFSF11, CD254, ODF, OPGL, OPTB2, RANKL, TRANCE, hRANKL2, sOdf, TNLG6B, tumor necrosis factor superfamily member 11, TNF superfamily member 11
External IDsOMIM: 602642 MGI: 1100089 HomoloGene: 2744 GeneCards: TNFSF11
Orthologs
SpeciesHumanMouse
Entrez

8600

21943

Ensembl

ENSG00000120659

ENSMUSG00000022015

UniProt

O14788

O35235

RefSeq (mRNA)

NM_003701
NM_033012

NM_011613

RefSeq (protein)

NP_003692
NP_143026

NP_035743

Location (UCSC)Chr 13: 42.56 – 42.61 MbChr 14: 78.51 – 78.55 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

RANKL is known as a type II membrane protein and is a member of the tumor necrosis factor (TNF) superfamily. RANKL has been identified to affect the immune system and control bone regeneration and remodeling. RANKL is an apoptosis regulator gene, a binding partner of osteoprotegerin (OPG), a ligand for the receptor RANK and controls cell proliferation by modifying protein levels of Id4, Id2 and cyclin D1. RANKL is expressed in several tissues and organs including: skeletal muscle, thymus, liver, colon, small intestine, adrenal gland, osteoblast, mammary gland epithelial cells, prostate and pancreas. Variation in concentration levels of RANKL throughout several organs reconfirms the importance of RANKL in tissue growth (particularly bone growth) and immune functions within the body.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.